Literature DB >> 2510805

Intracellular metabolism of biogenic amines in paraneurons.

H Hasegawa1, T Kobayashi, F Inoue, A Ichiyama.   

Abstract

Serotonin is one of the representative biogenic amines produced from tryptophan in the gastrointestinal tract as well as in the brain. The pineal gland also synthesizes serotonin, but as an intermediate in the biosynthesis of melatonin. The first enzymic step in the biosynthesis of serotonin is the hydroxylation of L-tryptophan catalyzed by tryptophan 5-monooxygenase. The 5-hydroxy-L-tryptophan (L-5HTP) formed is then decarboxylated to serotonin. Since the second step is catalyzed by non-specific aromatic L-amino acid decarboxylase, whether or not a given cell has the capacity to synthesize serotonin depends on the existence of tryptophan monooxygenase, and regulation of the serotonin biosynthesis is achieved mainly by modulating the activity of the first step enzyme. The activity of tryptophan monooxygenase was detected in extracts of the mouse stomach and intestines, although this activity was as low as approximately 1/20 of that in similar extract of the mouse brainstem. The upper small intestine and colon had a higher level of activity than other parts, and in the upper small intestine the enzyme was found to reside primarily in enterochromaffin cells of the mucosa. The intestinal tryptophan monooxygenase shared a common antigenic character with the enzyme from murine mastocytoma and was immunologically different from the brain enzyme. The enzymic properties were also similar to those of mastocytoma tryptophan monooxygenase which requires loosely-bound functional iron (Fe2+) for the activity. It seemed likely that the activity of tryptophan monooxygenase in paraneurons such as mastocytoma and enterochromaffin cells depends on available ferrous iron, and is therefore regulated, at least in part, by the cytosolic level of chelatable iron.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2510805     DOI: 10.1679/aohc.52.suppl_69

Source DB:  PubMed          Journal:  Arch Histol Cytol        ISSN: 0914-9465


  4 in total

1.  The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome.

Authors:  Philip M Brown; Douglas A Drossman; Alastair J J Wood; Gary A Cline; Kenny S Frazier; Jessica I Jackson; Johanna Bronner; Joel Freiman; Brian Zambrowicz; Arthur Sands; Michael D Gershon
Journal:  Gastroenterology       Date:  2011-05-18       Impact factor: 22.682

2.  Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters.

Authors:  J J Chen; Z Li; H Pan; D L Murphy; H Tamir; H Koepsell; M D Gershon
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

3.  Intestinal 5-hydroxytryptamine and mast cell infiltration in rat experimental colitis.

Authors:  F Magro; S Fraga; I Azevedo; P Soares-da-Silva
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

4.  The Leydig cell of the human testis--a new member of the diffuse neuroendocrine system.

Authors:  M S Davidoff; W Schulze; R Middendorff; A F Holstein
Journal:  Cell Tissue Res       Date:  1993-03       Impact factor: 5.249

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.